Jennison Associates
CLVS

Jennison Associates’s Clovis Oncology, Inc. CLVS Stock Holding History

Jennison Associates’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-690,563
Closed -$31.4M – 715
2018
Q2 		$31.4M Sell
690,563
-7,013
-1% -$341K 0.03% 334
2018
Q1 		$36.8M Buy
697,576
+93,904
+16% +$5.48M 0.04% 298
2017
Q4 		$41M Buy
603,672
+3,503
+0.6% +$245K 0.04% 289
2017
Q3 		$49.5M Sell
600,169
-585,008
-49% -$46.4M 0.05% 275
2017
Q2 		$111M Buy
1,185,177
+817,677
+222% +$50M 0.12% 133
2017
Q1 		$23.4M Sell
367,500
-82,747
-18% -$5.03M 0.03% 405
2016
Q4 		$20M Buy
450,247
+29,517
+7% +$1.04M 0.02% 410
2016
Q3 		$15.2M Buy
+420,730
New +$9.03M 0.02% 443
2013
Q3 		– Sell
-56,959
Closed -$3.81M – 725
2013
Q2 		$3.81M Buy
+56,959
New +$2.56M ﹤0.01% 499

Other funds holding CLVS

PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PC
PointState Capital New York $4.31B AUM 42.31% 1-Year Est. Return
O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $950M AUM 57.92% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $718M AUM 8.19% 1-Year Est. Return